Wednesday, April 01, 2015 7:55:16 AM
http://cto-iov.csa-acvm.ca/SearchArticles.asp?Instance=101&Form=1&Attr3=1&Attr1=1&Attr1=2&Attr1=3&Attr1=4&Attr1=5&AttrSet4=1
Background
1. Enterra Corporation (the Issuer) is an OTC reporting issuer under Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets and has been an OTC reporting issuer since at least 14 July 2014.
2. The Issuer has failed to file any of the periodic disclosure required under section 146 of the Securities Act (Alberta) (the Act) since that date.
Decision
3. Under section 33.1 of the Act, it is ordered that trading or purchasing cease in respect of each security of the Issuer until this order has been revoked or varied.
http://cto-iov.csa-acvm.ca/ArticleFile.asp?Instance=101&ID=B1E98CAE25C34645BA6ED4E3FE7AEFD2
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM